My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 150

    1.

    Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.

    Wang CJ, Chou FC, Chu CH, Wu JC, Lin SH, Chang DM, Sytwu HK.

    Diabetes. 2008 Jul;57(7):1861-9. Epub 2008 Apr 16.PMID: 18420489 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Tissue expression of PD-L1 mediates peripheral T cell tolerance.

    Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH.

    J Exp Med. 2006 Apr 17;203(4):883-95. Epub 2006 Apr 10.PMID: 16606670 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.

    Ansari MJ, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, Yamazaki T, Azuma M, Iwai H, Khoury SJ, Auchincloss H Jr, Sayegh MH.

    J Exp Med. 2003 Jul 7;198(1):63-9.PMID: 12847137 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.

    Hussain S, Delovitch TL.

    J Immunol. 2005 Jan 15;174(2):680-7.PMID: 15634886 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.

    Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway CA Jr, Flavell RA.

    J Exp Med. 1996 Nov 1;184(5):1963-74.PMID: 8920883 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.

    Tian C, Ansari MJ, Paez-Cortez J, Bagley J, Godwin J, Donnarumma M, Sayegh MH, Iacomini J.

    J Immunol. 2007 Nov 15;179(10):6762-9.PMID: 17982066 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.

    Fife BT, Guleria I, Gubbels Bupp M, Eagar TN, Tang Q, Bour-Jordan H, Yagita H, Azuma M, Sayegh MH, Bluestone JA.

    J Exp Med. 2006 Nov 27;203(12):2737-47. Epub 2006 Nov 20.PMID: 17116737 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.

    Christianson SW, Shultz LD, Leiter EH.

    Diabetes. 1993 Jan;42(1):44-55.PMID: 8093606 [PubMed - indexed for MEDLINE]Related articles

    9.

    Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

    Lucas JA, Menke J, Rabacal WA, Schoen FJ, Sharpe AH, Kelley VR.

    J Immunol. 2008 Aug 15;181(4):2513-21.PMID: 18684942 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.

    Gallichan WS, Balasa B, Davies JD, Sarvetnick N.

    J Immunol. 1999 Aug 1;163(3):1696-703.PMID: 10415077 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.

    Stephens LA, Kay TW.

    Int Immunol. 1995 Dec;7(12):1885-95.PMID: 8746558 [PubMed - indexed for MEDLINE]Related articles

    12.

    Interaction of programmed death-1 and programmed death-1 ligand-1 contributes to testicular immune privilege.

    Cheng X, Dai H, Wan N, Moore Y, Vankayalapati R, Dai Z.

    Transplantation. 2009 Jun 27;87(12):1778-86.PMID: 19543053 [PubMed - indexed for MEDLINE]Related articles

    13.

    Beta-cell apoptosis in an accelerated model of autoimmune diabetes.

    Augstein P, Stephens LA, Allison J, Elefanty AG, Ekberg M, Kay TW, Harrison LC.

    Mol Med. 1998 Aug;4(8):495-501.PMID: 9742505 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Transplantation of NIT-1 cells expressing pD-L1 for treatment of streptozotocin-induced diabetes.

    Wen X, Zhu H, Li L, Li Y, Wang M, Liu J, Yang D, Liao W, Shen G.

    Transplantation. 2008 Dec 15;86(11):1596-602.PMID: 19077895 [PubMed - indexed for MEDLINE]Related articles

    15.

    Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart.

    Grabie N, Gotsman I, DaCosta R, Pang H, Stavrakis G, Butte MJ, Keir ME, Freeman GJ, Sharpe AH, Lichtman AH.

    Circulation. 2007 Oct 30;116(18):2062-71. Epub 2007 Oct 15.PMID: 17938288 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

    Fife BT, Pauken KE, Eagar TN, Obu T, Wu J, Tang Q, Azuma M, Krummel MF, Bluestone JA.

    Nat Immunol. 2009 Nov;10(11):1185-92. Epub 2009 Sep 27.PMID: 19783989 [PubMed - indexed for MEDLINE]Related articles

    17.

    A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.

    Balasa B, La Cava A, Van Gunst K, Mocnik L, Balakrishna D, Nguyen N, Tucker L, Sarvetnick N.

    J Immunol. 2000 Dec 15;165(12):7330-7.PMID: 11120869 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.

    Yadav D, Hill N, Yagita H, Azuma M, Sarvetnick N.

    Cell Immunol. 2009;258(2):161-71. Epub 2009 May 6.PMID: 19497561 [PubMed - indexed for MEDLINE]Related articles

    19.

    Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.

    Silva DG, Petrovsky N, Socha L, Slattery R, Gatenby P, Charlton B.

    J Immunol. 2003 May 15;170(10):4996-5002.PMID: 12734343 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.

    Trembleau S, Gregori S, Penna G, Gorny I, Adorini L.

    J Immunol. 2001 Oct 1;167(7):4104-14.PMID: 11564833 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity